ClinicalTrials.gg
CompletedNCT07889011HNC-AMUpdated Oct 22, 2026

Effect of Abdominal Massage on Gastrointestinal Symptoms After Head and Neck Cancer Surgery

An interventional study of Abdominal Massage in Abdominal Massage, Enteral Nutrition and Nasogastric Feeding, sponsored by Maltepe University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Maltepe University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Oct 2024, registered Oct 2026).
Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aimed to evaluate whether abdominal massage could reduce abdominal pain, constipation, and gas/bloating in patients receiving enteral nutrition through a nasogastric tube after surgery for head and neck cancer.

A total of 70 patients participated in this randomized controlled trial. Participants were randomly assigned to one of two groups. The intervention group (35 patients) received abdominal massage for 15 minutes twice daily over three consecutive postoperative days, in addition to routine nursing care. The control group (35 patients) received routine nursing care without abdominal massage. Abdominal pain, constipation, and gas/bloating were assessed using standardized measurement tools. Assessments were performed twice daily, in the morning and evening, during the first three postoperative days.

The study was conducted to investigate whether abdominal massage could be a useful non-drug nursing intervention for managing gastrointestinal symptoms in patients recovering from head and neck cancer surgery.

Read the detailed description

Patients undergoing surgery for head and neck cancer may experience difficulties with oral intake and require enteral nutrition through a nasogastric tube during postoperative recovery. Gastrointestinal symptoms such as abdominal pain, constipation, gas, and bloating may occur during enteral feeding and can negatively affect patient comfort and recovery.

Abdominal massage is a non-pharmacological nursing intervention that may help stimulate intestinal motility, support bowel function, and relieve gastrointestinal discomfort. Although abdominal massage has been investigated in various patient populations, evidence regarding its effects in patients receiving enteral nutrition following head and neck cancer surgery remains limited.

This single-center, parallel-group randomized controlled trial was conducted in the Otorhinolaryngology Department of Istanbul University, Istanbul Faculty of Medicine Hospital, Türkiye, between October 2024 and August 2025.

The study included 70 patients who underwent head and neck cancer surgery and received enteral nutrition through a nasogastric tube. Participants were allocated to an intervention group (n = 35) or a control group (n = 35) using simple randomization. Patients in the intervention group received abdominal massage in addition to standard postoperative treatment and nursing care. The massage was administered by the researcher nurse for 15 minutes twice daily, in the morning and evening, over three consecutive postoperative days. Each session was performed 30 minutes after bolus enteral feeding. Patients in the control group continued to receive standard postoperative treatment and nursing care without abdominal massage. Gastrointestinal symptoms were evaluated using the Numeric Rating Scale for pain intensity, the Constipation Assessment Scale, and the Gas/Bloating Scale. Measurements were obtained twice daily during the first three postoperative days, resulting in six assessment time points. The study was designed to determine whether abdominal massage could provide a practical, non-invasive, and non-pharmacological approach to managing gastrointestinal symptoms in patients receiving enteral nutrition after head and neck cancer surgery. The findings may contribute to the development of supportive nursing interventions for postoperative symptom management in oncology care.

02

Conditions studied

  • Abdominal Massage
  • Enteral Nutrition
  • Nasogastric Feeding
  • Head and Neck Surgery
  • Oncology Nursing
  • Randomized Controlled Trial
  • Gastrointestinal Symptoms

Keywords

  • Abdominal Massage
  • Head and Neck Cancer
  • Enteral Nutrition
  • Nasogastric Feeding
  • Abdominal Pain
  • Constipation
  • Gas and Bloating
  • Oncology Nursing
03

In context

Head and Neck Neoplasms

2,403 studies on the registry are indexed under Head and Neck Neoplasms; 559 are open to participants now.

This study's enrollment of 70 is above the median of 47 across 1,791 interventional studies indexed under Head and Neck Neoplasms.

Browse Head and Neck Neoplasms studies →

Lead sponsor

Maltepe University is the lead sponsor of 67 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older.
  • Underwent head and neck surgery.
  • Able to communicate in Turkish.
  • Receiving inpatient treatment and nursing care.
  • Receiving enteral nutrition through a nasogastric tube.
  • No symptoms of diarrhea.
  • No physician-diagnosed chronic constipation.
  • Conscious and oriented to person, place, and time.
  • No contraindications to abdominal massage, including inflammatory bowel disease, abdominal tumors, a history of abdominal surgery or radiotherapy to the abdominal region, ileus or suspected ileus, or pregnancy.
  • Not bedridden or wheelchair-dependent.
  • Willing to participate in the study and providing informed consent.

Exclusion criteria

Exclusion Criteria:

  • History of bowel resection.
  • History of abdominal surgery.
  • Uncontrolled psychiatric illness.
  • Active lower gastrointestinal bleeding.
  • Use of laxatives or suppositories, or administration of enemas.
  • Refusal to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • No intervention
    control

    Participants assigned to the control group (n = 35) received standard postoperative treatment and routine nursing care following head and neck cancer surgery. All participants received enteral nutrition through a nasogastric tube. No abdominal massage was administered to this group. Gastrointestinal symptoms, including abdominal pain, constipation, and gas/bloating, were assessed twice daily over three consecutive postoperative days using the same measurement tools and assessment schedule as the intervention group.

  • Experimental
    abdominal massage

    Abdominal massage was administered by the researcher nurse to patients receiving enteral nutrition through a nasogastric tube following head and neck cancer surgery. The intervention consisted of 15-minute massage sessions performed twice daily (morning and evening) for three consecutive postoperative days. Each session was performed 30 minutes after bolus enteral feeding. Abdominal massage was provided in addition to standard postoperative treatment and routine nursing care.

    Other: Abdominal Massage

Interventions

  • OtherAbdominal Massage

    Abdominal massage was administered by the researcher nurse to patients receiving enteral nutrition through a nasogastric tube following head and neck cancer surgery. The intervention consisted of 15-minute massage sessions performed twice daily (morning and evening) for three consecutive postoperative days. Each session was performed 30 minutes after bolus enteral feeding. Abdominal massage was provided in addition to standard postoperative treatment and routine nursing care.

06

What researchers measure

Primary outcomes

  1. Abdominal Pain Intensity

    Abdominal pain intensity was assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.

    Time frame: Twice daily (morning and evening) on postoperative days 1, 2, and 3 (six assessments over three days).

  2. Constipation Severity

    Constipation was assessed using the Constipation Assessment Scale (CAS). Total scores range from 0 to 16, with higher scores indicating greater constipation severity.

    Time frame: Twice daily (morning and evening) on postoperative days 1, 2, and 3 (six assessments over three days).

  3. Gas and Bloating Severity

    Gas and bloating symptoms were assessed using the Gas/Bloating Scale. Higher scores indicate greater symptom severity.

    Time frame: Twice daily (morning and evening) on postoperative days 1, 2, and 3 (six assessments over three days).

07

Study locations

1 site
  • Istanbul University, Istanbul Faculty of Medicine Hospital
    Istanbul, 34093, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Aug 2025, 10 months.

Of 412 non-industry interventional studies with no phase under Head and Neck Neoplasms, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 67. This study's 10 months is below that.

Counting every sponsor, half of 427 studies reached it within 34 months; a quarter within 18 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 22, 2026
StartActual
Oct 30, 2024
Primary completionActual
Aug 30, 2025
CompletionActual
Aug 30, 2025
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07889011
Lead sponsor
Maltepe University
Responsible party
Hatice Erdoğan (Assist. Prof., Maltepe University) — Principal investigator
First posted
Oct 22, 2026
Start date
Oct 30, 2024
Primary completion
Aug 30, 2025
Completion
Aug 30, 2025
Last update
Oct 22, 2026

Study contacts

Hatice Erdoğan
study chair · Maltepe Üniversitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion